Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in cystic fibrosis patients

BOUCHERVILLE, QC, March 31, 2016 (GLOBE NEWSWIRE) — Sandoz Canada Inc. announced the launch of Prtobramycin Inhalation Solution, an authorized generic version of PrTOBI*, currently marketed by Novartis Pharmaceuticals Canada Inc. PrTOBRAMYCIN INHALATION SOLUTION, a respiratory antibiotic, is indicated for the management of cystic fibrosis patients with chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infections. “We are proud to bring an authorized generic version of PrTOBI* to Canadian patients with cystic fibrosis and suffering from chronic pulmonary infections,” said Michel Robidoux, President and General Manager of Sandoz Canada Inc. “This launch is in line with our commitment to offer high-quality, affordable […]

Share the post

Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in cystic fibrosis patients

×

Subscribe to Bloggerwave Inc. Is In The Stockguru Spotlight For October 22, 2010 | Stockguru Smallcap Alerts On Penny Stocks

Get updates delivered right to your inbox!

Thank you for your subscription

×